LINKPH.BO · BSE
LINK PHARMA CHEM LTD.
₹27.86
+3.22% (+₹0.87)
Prev. close
₹26.99
Volume
2,761
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About LINK PHARMA CHEM LTD.
Link Pharma Chem Limited engages in the manufacturing and selling of drugs intermediates for pharmaceutical, agriculture, cosmetics, and veterinary Industries in India. It also engages in custom synthesis/contract manufacturing for multistage synthesis for small, medium, and large companies; development of multistep pathways for organic synthesis; and refinement and optimization of existing synthetic methods. In addition, the company offers fragrance intermediates. Link Pharma Chem Limited was incorporated in 1984 and is based in Vadodara, India.
Details
Sector
Basic Materials
Industry
Chemicals
CEO
Mr. Satish Ganpatro Thakur
Headquarters
Vadodara
Employees
83
Website
linkpharmachem.co.inExchange
View on BSE ↗Key stats
Market cap
₹12.37 Cr
P/E ratio (TTM)
158.8
EPS (TTM)
₹-0.02
Beta (1Y · daily vs NIFTY 50)
1.22
Beta (5Y · monthly vs NIFTY 50)
0.89
Shares float
16.75 L
EPS · quarter ended Jun 2026
₹0.72
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹34.81 Cr | ₹53.56 Cr | ₹38.76 Cr | ₹29.90 Cr | ₹25.43 Cr | ₹27.43 Cr | |
| EBITDA | ₹2.99 Cr | ₹4.00 Cr | ₹2.56 Cr | ₹-95,000 | ₹31.58 L | ₹1.64 Cr |
| ₹1.09 Cr | ₹1.88 Cr | ₹65.42 L | ₹-1.36 Cr | ₹-1.03 Cr | ₹7.69 L | |
| Diluted EPS | ₹2.44 | ₹4.24 | ₹1.47 | ₹-3.07 | ₹-2.31 | ₹0.17 |
Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹32.46 Cr | ₹25.95 Cr | ₹23.29 Cr | ₹24.96 Cr | |
| — | — | ₹8.76 Cr | ₹9.22 Cr | ₹5.78 Cr | ₹7.30 Cr | |
| Stockholders' equity | — | — | ₹15.04 Cr | ₹13.71 Cr | ₹12.66 Cr | ₹12.79 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹-1.71 Cr | ₹-2.80 L | ₹2.69 Cr | ₹2.15 Cr | |
| Investing cash flow | — | — | ₹-7.50 L | ₹40.52 L | ₹1.53 Cr | ₹-2.66 Cr |
| — | — | ₹1.61 Cr | ₹-40.70 L | ₹-4.21 Cr | ₹99.20 L | |
| Capital expenditure | — | — | ₹-89.29 L | ₹-95.03 L | ₹-25.72 L | ₹-2.10 Cr |
| End cash position | — | — | ₹9.39 L | ₹6.42 L | ₹6.45 L | ₹54.59 L |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Basic Materials
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| UltraTech Cement Limited | ₹3.17 L Cr | ₹11,014 | 36.9 | 4.13 | 10.7% | 0.31 | +16.6% | -12.8% |
| JSW Steel Limited | ₹3.06 L Cr | ₹1,275.6 | 12.4 | 3.06 | 22.3% | 1.19 | +9.3% | +13.8% |
| Hindustan Zinc Limited | ₹2.42 L Cr | ₹596 | 14.2 | 10.69 | 61.1% | 0.39 | +18.6% | +31.0% |
| Asian Paints Limited | ₹2.35 L Cr | ₹2,451.3 | 49.3 | 11.01 | 20.2% | 0.18 | +5.1% | -1.1% |
| Tata Steel Limited | ₹2.28 L Cr | ₹187.29 | 20.7 | 2.23 | 10.6% | 0.90 | +6.2% | +9.3% |
| Hindalco Industries Limited | ₹2.18 L Cr | ₹986.5 | 13.3 | 1.59 | 9.8% | 0.73 | +15.0% | +31.5% |
| Grasim Industries Limited | ₹2.15 L Cr | ₹3,209.2 | 37.9 | 2.08 | 4.8% | 2.20 | +18.2% | +11.5% |
| Solar Industries India Limited | ₹1.71 L Cr | ₹18,815 | 86.1 | 27.25 | 26.7% | 0.29 | +30.6% | +27.0% |
| Vedanta Aluminium Metal Limited | ₹1.60 L Cr | ₹416.5 | 42.1 | — | — | — | — | — |
| Pidilite Industries Limited | ₹1.58 L Cr | ₹1,572.1 | 59.8 | 14.58 | 22.6% | 0.04 | +11.1% | -48.5% |
| JINDAL STEEL LIMITED | ₹1.11 L Cr | ₹1,103 | 41.1 | 2.19 | 6.6% | 0.44 | +5.5% | +4.7% |
| LINK PHARMA CHEM LTD. | ₹11.99 Cr | ₹27.26 | 158.8 | 0.94 | 0.6% | 0.57 | +7.9% | -28.2% |
Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 28
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.